Table 1.
Classification | CFTR defect | Mutation examples | Required approaches | Drug required (Approved?) |
---|---|---|---|---|
Class I | No functional CFTR protein/mRNA | G542X, W1282X, R553X | Salvage protein synthesis | Bypass therapy (no), Read through agents (no) |
Class II | CFTR trafficking defect | ΔF508, ΔI507, N1303K | Correct protein folding | Corrector (yes) |
Class III | Impaired gating | G551D, V520F, S549N | Recover channel conductance | Potentiator (yes) |
Class IV | Decreased channel conductance | R334W, R117H, S1235R | Recover channel conductance | Potentiator (only for R117H) |
Class V | Reduced production of CFTR | A455E, 1680-886A→G | Improve maturation/correct splicing | Antisense oligonucleotides (no), Corrector (no), Amplifier (no) |
Class VI | Decreased CFTR stability | Q1412X, 4279 insA | Promote protein stability | Stabilisers (no) |
CFTR, cystic fibrosis transmembrane conductance regulator.